v3.26.1
Condensed Consolidated Statements of Changes in Common Shareholders' Equity (Unaudited) - USD ($)
$ in Millions
Total
Common shares
Treasury shares
Paid-in-surplus
Retained earnings
AOCI
 [1]
Beginning balance (in shares) at Dec. 31, 2024   1,113,000,000        
Beginning balance (in shares) at Dec. 31, 2024     (508,800,000)      
Beginning balance at Dec. 31, 2024 $ 16,890 $ 2,783 $ (56,132) $ 5,334 $ 65,628 $ (723)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Share repurchase programs (Note 16) (in shares) (5,745,601)          
Ending balance (in shares) at Mar. 31, 2025   1,113,200,000        
Ending balance (in shares) at Mar. 31, 2025     (514,200,000)      
Ending balance at Mar. 31, 2025 $ 16,039 $ 2,783 $ (57,549) 5,075 66,450 (720)
Beginning balance (in shares) at Dec. 31, 2024   1,113,000,000        
Beginning balance (in shares) at Dec. 31, 2024     (508,800,000)      
Beginning balance at Dec. 31, 2024 16,890 $ 2,783 $ (56,132) 5,334 65,628 (723)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 3,502       3,502  
Other comprehensive income/(loss) 31 [2]         31
Conversion, stock option exercises, forfeitures, ESPP, and other (in shares) [3]   200,000 500,000      
Conversion, stock option exercises, forfeitures, ESPP, and other [3] $ 127   $ 39 88    
Share repurchase programs (Note 16) (in shares) (11,857,159)   (11,900,000)      
Share repurchase programs (Note 16) $ (2,694)   $ (2,777) 83    
Dividends declared (1,598)       (1,598)  
Ending balance (in shares) at Jun. 30, 2025   1,113,200,000        
Ending balance (in shares) at Jun. 30, 2025     (520,200,000)      
Ending balance at Jun. 30, 2025 16,258 $ 2,783 $ (58,870) 5,505 67,532 (692)
Beginning balance (in shares) at Mar. 31, 2025   1,113,200,000        
Beginning balance (in shares) at Mar. 31, 2025     (514,200,000)      
Beginning balance at Mar. 31, 2025 16,039 $ 2,783 $ (57,549) 5,075 66,450 (720)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 1,876       1,876  
Other comprehensive income/(loss) 28 [4]         28
Conversion, stock option exercises, forfeitures, ESPP, and other (in shares) [3]     100,000      
Conversion, stock option exercises, forfeitures, ESPP, and other [3] $ 62   $ 15 47    
Share repurchase programs (Note 16) (in shares) (6,111,558)   (6,100,000)      
Share repurchase programs (Note 16) $ (953)   $ (1,336) 383    
Dividends declared (794)       (794)  
Ending balance (in shares) at Jun. 30, 2025   1,113,200,000        
Ending balance (in shares) at Jun. 30, 2025     (520,200,000)      
Ending balance at Jun. 30, 2025 16,258 $ 2,783 $ (58,870) 5,505 67,532 (692)
Beginning balance (in shares) at Mar. 31, 2025   1,113,200,000        
Beginning balance (in shares) at Mar. 31, 2025     (514,200,000)      
Beginning balance at Mar. 31, 2025 $ 16,039 $ 2,783 $ (57,549) 5,075 66,450 (720)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Share repurchase programs (Note 16) (in shares) (6,100,000)          
Ending balance (in shares) at Jun. 30, 2026 593,957,035 1,113,400,000        
Ending balance (in shares) at Jun. 30, 2026     (519,400,000)      
Ending balance at Jun. 30, 2026 $ 20,673 $ 2,783 $ (58,815) 5,677 71,584 (556)
Beginning balance (in shares) at Dec. 31, 2025 593,245,884 1,113,200,000        
Beginning balance (in shares) at Dec. 31, 2025     (519,900,000)      
Beginning balance at Dec. 31, 2025 $ 18,467 $ 2,783 $ (58,843) 5,589 69,529 (591)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Share repurchase programs (Note 16) (in shares) 0          
Ending balance (in shares) at Mar. 31, 2026   1,113,400,000        
Ending balance (in shares) at Mar. 31, 2026     (519,700,000)      
Ending balance at Mar. 31, 2026 $ 19,418 $ 2,783 $ (58,844) 5,621 70,411 (553)
Beginning balance (in shares) at Dec. 31, 2025 593,245,884 1,113,200,000        
Beginning balance (in shares) at Dec. 31, 2025     (519,900,000)      
Beginning balance at Dec. 31, 2025 $ 18,467 $ 2,783 $ (58,843) 5,589 69,529 (591)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 3,694       3,694  
Other comprehensive income/(loss) 35 [2]         35
Conversion, stock option exercises, forfeitures, ESPP, and other (in shares) [3]   200,000 500,000      
Conversion, stock option exercises, forfeitures, ESPP, and other [3] $ 116   $ 28 88    
Share repurchase programs (Note 16) (in shares) 0          
Share repurchase programs (Note 16) $ 0          
Dividends declared $ (1,639)       (1,639)  
Ending balance (in shares) at Jun. 30, 2026 593,957,035 1,113,400,000        
Ending balance (in shares) at Jun. 30, 2026     (519,400,000)      
Ending balance at Jun. 30, 2026 $ 20,673 $ 2,783 $ (58,815) 5,677 71,584 (556)
Beginning balance (in shares) at Mar. 31, 2026   1,113,400,000        
Beginning balance (in shares) at Mar. 31, 2026     (519,700,000)      
Beginning balance at Mar. 31, 2026 19,418 $ 2,783 $ (58,844) 5,621 70,411 (553)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 1,993       1,993  
Other comprehensive income/(loss) (3) [4]         (3)
Conversion, stock option exercises, forfeitures, ESPP, and other (in shares) [3]     300,000      
Conversion, stock option exercises, forfeitures, ESPP, and other [3] $ 85   $ 29 56    
Share repurchase programs (Note 16) (in shares) 0          
Share repurchase programs (Note 16) $ 0          
Dividends declared $ (820)       (820)  
Ending balance (in shares) at Jun. 30, 2026 593,957,035 1,113,400,000        
Ending balance (in shares) at Jun. 30, 2026     (519,400,000)      
Ending balance at Jun. 30, 2026 $ 20,673 $ 2,783 $ (58,815) $ 5,677 $ 71,584 $ (556)
[1] AOCI = accumulated other comprehensive income/loss (Note 9)
[2] Net of deferred taxes of ($0.1) million and ($1.9) million during the six months ended June 30, 2026 and 2025, respectively.
[3] ESPP = employee stock purchase plan
[4] Net of deferred taxes of $0.0 million and ($1.7) million during the three months ended June 30, 2026 and 2025, respectively.